Propranolol Dosing Frequency
For infantile hemangiomas, propranolol should be taken three times daily (divided into three doses throughout the day), though twice-daily dosing may be acceptable for uncomplicated cases at the discretion of the treating clinician. 1
Dosing Schedule Based on Indication
For Infantile Hemangiomas (Primary Evidence)
The British Society for Paediatric Dermatology and American Academy of Pediatrics guidelines provide the clearest dosing framework:
Standard regimen: Total daily dose divided into three doses per day 1, 2
- Starting dose: 1 mg/kg/day divided into three doses
- Maintenance dose: 2 mg/kg/day divided into three doses
- Can increase after 24 hours from starting dose
Alternative for uncomplicated cases: The dose may be divided into two or three daily doses at the treating clinician's discretion 1
High-risk patients (PHACE syndrome, arterial abnormalities): Should receive three times daily dosing to minimize abrupt blood pressure changes 2
Critical Timing Considerations
Propranolol must be administered with or after feeding, and doses should be held during times of poor oral intake or vomiting to prevent hypoglycemia 2. Parents should ensure regular feeding schedules, and if the child becomes unwell with reduced feeding, propranolol must be stopped until normal feeding resumes 1.
For Adult Cardiovascular Indications (Extended-Release vs. Immediate-Release)
The FDA labeling distinguishes between formulations:
Extended-release capsules: Once daily dosing 3
- Hypertension: 80-160 mg once daily
- Angina: 80-320 mg once daily
- Migraine prophylaxis: 80-240 mg once daily
Immediate-release tablets: Research shows that for cardiovascular conditions, twice-daily dosing is as effective as four-times-daily dosing 4, 5, 6
Important Caveats
Do not assume different formulations are interchangeable. Extended-release capsules produce lower blood levels and have different kinetics than immediate-release tablets—they are not mg-for-mg substitutes 3. Retitration is necessary when switching formulations.
Once-daily dosing of immediate-release propranolol for hypertension may result in loss of blood pressure control at the end of the dosing interval 7, making it less reliable than twice-daily or extended-release formulations.
For infantile hemangiomas specifically, the three-times-daily schedule is preferred because it maintains more stable drug levels in young infants who are at higher risk for adverse effects, particularly hypoglycemia and hemodynamic instability.